Mexico’s antitrust commission opened an investigation into possible monopolistic practices in the medicines sector, which has been under scrutiny since a leak earlier this year from the Panama papers revealed a questioned deal involving the country’s largest private drug distributor.
In a statement Wednesday, the federal competition commission said “some public information” prompted the investigation, which was opened in May. The commission can initiate probes before making them public to determine whether there are grounds for continuing the investigation.
The commission said it is investigating possible monopolist practices, such as price-fixing or allocation of customers between market players, in the production, distribution and sale of medicines in Mexico.
The commission said the investigation includes the purchase of the country’s third-largest pharmaceutical distributor, Casa Marzam SA, by a little-known Dutch fund, since the companies involved are part of the distribution chain, although the overall investigation is much broader.
Full Content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletterr for more headlines and updates on antitrust developments around the world.
Featured News
Apple Prevails in Dismissal of Crypto-Payment Antitrust Lawsuit
Mar 27, 2024 by
CPI
Amazon Fined in Poland for Misleading Customers
Mar 27, 2024 by
CPI
Credit Card Rewards Under Threat as Visa, Mastercard Settlement Impacts Swipe Fees
Mar 27, 2024 by
CPI
UK Fashion Giants Commit to Honest Environmental Claims
Mar 27, 2024 by
CPI
Former Traders Lose Appeal Against Libor Rigging Conviction
Mar 27, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Real Estate & Antitrust
Mar 27, 2024 by
CPI
Systematic National Evidence of Steering by Real Estate Agents
Mar 27, 2024 by
CPI
Compliance Now! Actionable Antitrust Advice for the Residential Real Estate Industry
Mar 27, 2024 by
CPI
Real Estate Commissions: Some Insights from the Economics of Multi-Sided Platforms
Mar 27, 2024 by
CPI
New Ideas for Promoting Real Estate Brokerage Price Competition
Mar 27, 2024 by
CPI